Skip to main content
. 2002 Sep;76(18):9079–9086. doi: 10.1128/JVI.76.18.9079-9086.2002

TABLE 2.

Comparison of activities of selected HR2 peptides in plaque-forming and RT infectivity assays

Peptide Plaque-forming assaya
RT infectivity assaya
EC50 (μM) EC90 (μM) EC50 (μM) EC90 (μM)
T1569 0.026 0.117 0.055 0.106
T1577 0.050 0.162 0.098 0.177
T1578 0.020 0.090 0.053 0.157
T1588 0.030 0.125 0.168 0.423
a

EC50s and EC90s for each peptide were determined using the Karber method.